Voyager Therapeutics rises on upbeat Q4 earnings

Voyager Therapeutics

29/02/2024 13:28

** Shares of biotech co Voyager Therapeutics  VYGR.O  rise
19.1% to $10.69 premarket 
    ** Reports Q4 rev of $90.06 mln vs. est. of $20.64 mln -
LSEG data
    ** Reports Q4 EPS of $1.25 vs. loss of $0.61 yr earlier
    ** Records $80 mln in collaboration rev from deals with
Novartis  NOVN.S  and others
    ** Says has enough cash to meet planned operating expenses
and capital expenditure requirements into 2027     
    ** Co had cash, cash equivalents and marketable securities
of $230.9 mln as of Dec. 31
    ** Up to last close, stock down 24.9% in the last 12 months 

 (Reporting by Sneha S K)
 ((Sneha.SK@thomsonreuters.com;))